Groundbreaking research highlights the effectiveness of orforglipron in aiding weight loss for women at different stages of life. The findings, shared at the European Association for the Study of Diabetes Annual Meeting, reveal that participants lost as much as 14 percent of their body weight, regardless of whether they were premenopausal or postmenopausal.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.